PT1486206E - ¿utilizações para aminoácidos anticonvulsivantes para o tratamento de perturbações bipolares¿ - Google Patents
¿utilizações para aminoácidos anticonvulsivantes para o tratamento de perturbações bipolares¿ Download PDFInfo
- Publication number
- PT1486206E PT1486206E PT04021728T PT04021728T PT1486206E PT 1486206 E PT1486206 E PT 1486206E PT 04021728 T PT04021728 T PT 04021728T PT 04021728 T PT04021728 T PT 04021728T PT 1486206 E PT1486206 E PT 1486206E
- Authority
- PT
- Portugal
- Prior art keywords
- lower alkyl
- aryl
- heterocyclic
- unsubstituted
- substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22823000P | 2000-08-25 | 2000-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1486206E true PT1486206E (pt) | 2008-01-25 |
Family
ID=22856332
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT06012400T PT1695703E (pt) | 2000-08-25 | 2001-08-24 | Aminoácidos anticonvulsivantes para tratamento de neurose obsessivo-compulsiva |
PT01966230T PT1365787E (pt) | 2000-08-25 | 2001-08-24 | Utilização de anticonvulsivantes de aminoácidos para tratamento da dor. |
PT04021728T PT1486206E (pt) | 2000-08-25 | 2001-08-24 | ¿utilizações para aminoácidos anticonvulsivantes para o tratamento de perturbações bipolares¿ |
PT04021727T PT1486205E (pt) | 2000-08-25 | 2001-08-24 | ¿novas utilizações para aminoácidos anticonvulsivantes para tratamento da enxaqueca¿ |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT06012400T PT1695703E (pt) | 2000-08-25 | 2001-08-24 | Aminoácidos anticonvulsivantes para tratamento de neurose obsessivo-compulsiva |
PT01966230T PT1365787E (pt) | 2000-08-25 | 2001-08-24 | Utilização de anticonvulsivantes de aminoácidos para tratamento da dor. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT04021727T PT1486205E (pt) | 2000-08-25 | 2001-08-24 | ¿novas utilizações para aminoácidos anticonvulsivantes para tratamento da enxaqueca¿ |
Country Status (13)
Country | Link |
---|---|
US (6) | US6884910B2 (pt) |
EP (5) | EP1695703B1 (pt) |
JP (2) | JP4307068B2 (pt) |
AT (4) | ATE476971T1 (pt) |
AU (6) | AU2001286763C1 (pt) |
CA (2) | CA2419285C (pt) |
CY (5) | CY1107668T1 (pt) |
DE (4) | DE60127459T2 (pt) |
DK (4) | DK1486206T3 (pt) |
ES (5) | ES2294414T3 (pt) |
LU (1) | LU91512I2 (pt) |
PT (4) | PT1695703E (pt) |
WO (1) | WO2002015922A2 (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2419285C (en) * | 2000-08-25 | 2011-08-02 | Research Corporation Technologies, Inc. | New uses for amino acid anticonvulsants |
PT1243262E (pt) | 2001-03-20 | 2006-10-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica |
DK1243263T3 (da) * | 2001-03-21 | 2003-03-17 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte |
US20040087642A1 (en) * | 2002-10-24 | 2004-05-06 | Zeldis Jerome B. | Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain |
US20050233472A1 (en) * | 2003-09-19 | 2005-10-20 | Kao H P | Spotting high density plate using a banded format |
EP1537862A1 (en) * | 2003-12-02 | 2005-06-08 | Schwarz Pharma Ag | Novel use of peptide compounds for treating central neuropathic pain |
AU2004294714B2 (en) * | 2003-12-02 | 2009-12-10 | Ucb Pharma Gmbh | Novel use of peptide compounds for treating central neuropathic pain |
EP1579858A1 (en) * | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
CA2562937A1 (en) * | 2004-04-16 | 2005-10-27 | Schwarz Pharma Ag | Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
EP1604654A1 (en) * | 2004-05-18 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating dyskinesia |
EP1604655A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in trigeminal neuralgia |
US7427601B2 (en) * | 2004-06-24 | 2008-09-23 | Schwarz Pharma Ag | Method for treating tremor |
EA014055B1 (ru) * | 2004-08-27 | 2010-08-30 | Шварц Фарма Аг | Применение пептидных соединений для лечения боли при раке кости, а также боли, вызванной химиотерапией и нуклеозидами |
EP1629839A1 (en) * | 2004-08-27 | 2006-03-01 | Schwarz Pharma Ag | Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain |
US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
EP1920780A1 (en) * | 2006-10-12 | 2008-05-14 | Schwarz Pharma Ag | Peptide compounds for the treatment of hyperexcitability disorders |
TWI397417B (zh) * | 2006-06-15 | 2013-06-01 | Ucb Pharma Gmbh | 具有協同抗驚厥功效之醫藥組成物 |
CN101466390B (zh) * | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
US7489198B1 (en) | 2007-04-26 | 2009-02-10 | Lockheed Martin Corporation | Linear regulating switch |
WO2011101863A2 (en) | 2010-02-19 | 2011-08-25 | Cadila Healthcare Limited | Extended release pharmaceutical compositions of lacosamide |
AU2015280108B2 (en) * | 2014-06-23 | 2019-11-28 | Naurex, Inc. | Methods of treating or ameliorating migraine |
WO2017079169A1 (en) | 2015-11-03 | 2017-05-11 | Kimberly-Clark Worldwide, Inc. | Paper tissue with high bulk and low lint |
MX2020004101A (es) | 2017-11-29 | 2020-07-24 | Kimberly Clark Co | Lamina fibrosa con propiedades mejoradas. |
AU2018433810A1 (en) | 2018-07-25 | 2021-02-04 | Kimberly-Clark Worldwide, Inc. | Process for making three-dimensional foam-laid nonwovens |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE795788A (nl) * | 1972-02-22 | 1973-08-22 | Akzo Nv | Werkwijze ter bereiding van peptiden en peptide-derivaten en de toepassing hiervan |
US4533657A (en) * | 1981-07-24 | 1985-08-06 | Sterling Drug Inc. | Analgesic dipeptide amides and method of use and composition thereof |
US4510082A (en) * | 1983-03-07 | 1985-04-09 | Eli Lilly And Company | Pharmacologically active peptides |
FR2546517B1 (fr) * | 1983-05-24 | 1987-04-24 | Panmedica | Nouveaux dipeptides du -l-5-hydroxy-tryptophane, procedes pour leur preparation et medicaments les contenant |
JPH0680079B2 (ja) * | 1984-11-09 | 1994-10-12 | エーザイ株式会社 | ポリペプチド |
US5654301A (en) | 1985-02-15 | 1997-08-05 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
US5378729A (en) * | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
US5728680A (en) * | 1987-12-30 | 1998-03-17 | Cytoven J.V. | Methods for normalizing numbers of lymphocytes |
US5331089A (en) * | 1988-03-25 | 1994-07-19 | Merck Sharpe & Dohme, Ltd. | Peptides useful as tachykinin agonists |
US5178729A (en) * | 1991-01-15 | 1993-01-12 | James River Corporation Of Virginia | High purity stratified tissue and method of making same |
US5854217A (en) * | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
AU5890394A (en) | 1993-02-03 | 1994-08-29 | Steven Andrew Jennings | Blends of glycine derivatives and sugars |
ATE198551T1 (de) * | 1993-07-15 | 2001-01-15 | Hoffmann La Roche | Pharmazeutische kombination, die einen hemmer des renin-angiotensin-systems und einen endothelin- antagonisten enthält |
GB9318637D0 (en) * | 1993-09-08 | 1993-10-27 | Ferring Res Ltd | Enzyme inhibitors |
US5508266A (en) * | 1994-06-22 | 1996-04-16 | Ciba-Geigy Corporation | Gem-disubstituted amino acid derivatives |
US6348571B1 (en) * | 1994-09-12 | 2002-02-19 | Northwestern University | Corticotropin release inhibiting factor and methods of using same |
BR9509237A (pt) * | 1994-10-05 | 1997-10-21 | Chiroscience Ltd | Compostos peptidila e seu uso terapêutico como inibidores de metaloproteases |
US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
US5780589A (en) * | 1994-11-30 | 1998-07-14 | The United States Of America As Represented By The Department Of Health And Human Services | Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof |
US6037324A (en) * | 1996-01-04 | 2000-03-14 | Leukosite, Inc. | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor |
GB9601724D0 (en) | 1996-01-29 | 1996-03-27 | Merck Sharp & Dohme | Therapeutic agents |
US5773475A (en) | 1997-03-17 | 1998-06-30 | Research Corporation Technologies, Inc. | Anticonvulsant enantiomeric amino acid derivatives |
US6126939A (en) * | 1996-09-03 | 2000-10-03 | Yeda Research And Development Co. Ltd. | Anti-inflammatory dipeptide and pharmaceutical composition thereof |
US6514937B1 (en) * | 1997-02-25 | 2003-02-04 | Celtrix Pharmaceuticals, Inc. | Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
US6197746B1 (en) * | 1998-05-19 | 2001-03-06 | Repligen Corporation | Method of using secretin for treating autism |
WO1999002146A1 (fr) | 1997-07-08 | 1999-01-21 | Ono Pharmaceutical Co., Ltd. | Derives d'acide amine |
KR100522012B1 (ko) | 1997-07-08 | 2005-10-18 | 오노 야꾸힝 고교 가부시키가이샤 | 아미노산 유도체 |
ES2184300T3 (es) | 1997-07-15 | 2003-04-01 | Res Corp Technologies Inc | Derivados de aminoacidos utiles para tratar el accidente vascular encefalico. |
US6737408B1 (en) * | 1997-08-07 | 2004-05-18 | University Of Cincinnati | Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm |
US6028102A (en) * | 1998-02-24 | 2000-02-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Anticonvulsant drugs and pharmaceutical compositions thereof |
CA2601132C (en) | 1998-04-14 | 2011-11-08 | The General Hospital Corporation | Use of n-methylglycine and pharmaceutical compositions comprising n-methylglycine for treating neuropsychiatric disorders |
ES2262322T3 (es) | 1998-06-10 | 2006-11-16 | Meiji Seika Kaisha, Ltd. | Tratamiento de la degenaracion espinocereberal y comoposiciones utiles para el tratamiento de degeneracion espinocerebelar. |
US6716810B1 (en) * | 1998-12-09 | 2004-04-06 | Eleanor Roosevelt Institute | Composition and method for regulation of body weight and associated conditions |
US6399574B1 (en) * | 2000-03-22 | 2002-06-04 | University Of Utah Research Foundation | Use of conantokins |
CA2419285C (en) * | 2000-08-25 | 2011-08-02 | Research Corporation Technologies, Inc. | New uses for amino acid anticonvulsants |
US6228825B1 (en) | 2000-10-13 | 2001-05-08 | Colgate Palmolive Company | Automatic dishwashing cleaning system |
PT1243262E (pt) * | 2001-03-20 | 2006-10-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica |
-
2001
- 2001-08-24 CA CA2419285A patent/CA2419285C/en not_active Expired - Fee Related
- 2001-08-24 PT PT06012400T patent/PT1695703E/pt unknown
- 2001-08-24 DK DK04021728T patent/DK1486206T3/da active
- 2001-08-24 ES ES04021727T patent/ES2294414T3/es not_active Expired - Lifetime
- 2001-08-24 JP JP2002520843A patent/JP4307068B2/ja not_active Expired - Fee Related
- 2001-08-24 CA CA2740815A patent/CA2740815C/en not_active Expired - Fee Related
- 2001-08-24 ES ES04021728T patent/ES2294415T3/es not_active Expired - Lifetime
- 2001-08-24 ES ES01966230T patent/ES2281439T3/es not_active Expired - Lifetime
- 2001-08-24 US US09/938,677 patent/US6884910B2/en not_active Expired - Lifetime
- 2001-08-24 DE DE60127459T patent/DE60127459T2/de not_active Expired - Lifetime
- 2001-08-24 DE DE60131032T patent/DE60131032T2/de not_active Expired - Lifetime
- 2001-08-24 ES ES10160637T patent/ES2435000T3/es not_active Expired - Lifetime
- 2001-08-24 AU AU2001286763A patent/AU2001286763C1/en not_active Ceased
- 2001-08-24 EP EP06012400A patent/EP1695703B1/en not_active Expired - Lifetime
- 2001-08-24 PT PT01966230T patent/PT1365787E/pt unknown
- 2001-08-24 PT PT04021728T patent/PT1486206E/pt unknown
- 2001-08-24 AT AT06012400T patent/ATE476971T1/de active
- 2001-08-24 DK DK01966230T patent/DK1365787T3/da active
- 2001-08-24 AT AT01966230T patent/ATE357227T1/de active
- 2001-08-24 AT AT04021727T patent/ATE375792T1/de active
- 2001-08-24 WO PCT/US2001/026568 patent/WO2002015922A2/en active IP Right Grant
- 2001-08-24 EP EP10160637.4A patent/EP2210598B1/en not_active Expired - Lifetime
- 2001-08-24 DK DK06012400.5T patent/DK1695703T3/da active
- 2001-08-24 EP EP04021727A patent/EP1486205B1/en not_active Expired - Lifetime
- 2001-08-24 EP EP04021728A patent/EP1486206B1/en not_active Expired - Lifetime
- 2001-08-24 AT AT04021728T patent/ATE375793T1/de active
- 2001-08-24 PT PT04021727T patent/PT1486205E/pt unknown
- 2001-08-24 DK DK04021727T patent/DK1486205T3/da active
- 2001-08-24 ES ES06012400T patent/ES2348646T3/es not_active Expired - Lifetime
- 2001-08-24 DE DE60142806T patent/DE60142806D1/de not_active Expired - Lifetime
- 2001-08-24 DE DE60131033T patent/DE60131033T2/de not_active Expired - Lifetime
- 2001-08-24 EP EP01966230A patent/EP1365787B1/en not_active Expired - Lifetime
- 2001-08-24 AU AU8676301A patent/AU8676301A/xx active Pending
-
2003
- 2003-10-17 US US10/688,638 patent/US7148378B2/en not_active Expired - Lifetime
- 2003-10-17 US US10/688,709 patent/US7186859B2/en not_active Expired - Fee Related
-
2007
- 2007-01-10 US US11/651,845 patent/US7772427B2/en not_active Expired - Fee Related
- 2007-05-23 AU AU2007202336A patent/AU2007202336B9/en not_active Ceased
- 2007-06-11 CY CY20071100768T patent/CY1107668T1/el unknown
-
2008
- 2008-01-11 CY CY20081100041T patent/CY1107853T1/el unknown
- 2008-01-11 CY CY20081100040T patent/CY1107852T1/el unknown
- 2008-11-28 JP JP2008304255A patent/JP5190334B2/ja not_active Expired - Fee Related
-
2009
- 2009-01-14 LU LU91512C patent/LU91512I2/fr unknown
- 2009-02-18 CY CY200900002C patent/CY2009002I2/el unknown
- 2009-06-12 AU AU2009202363A patent/AU2009202363B2/en not_active Ceased
- 2009-06-12 AU AU2009202362A patent/AU2009202362B2/en not_active Ceased
-
2010
- 2010-07-01 US US12/829,160 patent/US8519183B2/en not_active Expired - Fee Related
- 2010-11-04 CY CY20101101002T patent/CY1112349T1/el unknown
-
2011
- 2011-05-17 AU AU2011202293A patent/AU2011202293B2/en not_active Ceased
-
2013
- 2013-07-29 US US13/953,213 patent/US20130316953A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1486206E (pt) | ¿utilizações para aminoácidos anticonvulsivantes para o tratamento de perturbações bipolares¿ | |
JP2007530493A5 (pt) | ||
JP2008501760A5 (pt) | ||
JP2007532607A5 (pt) | ||
JP2008501753A5 (pt) | ||
AR061743A1 (es) | Compuestos peptidicos para el tratamiento de trastornos de hiperexcitabilidad y trastornos asociados con disfuncion del canal de hierro | |
EA200601799A1 (ru) | Гидразидсодержащие соединения - ингибиторы cftr и их применение | |
NO971520L (no) | Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y | |
NO982731L (no) | Antagonister av gonadotropinfrigivende hormon | |
NO982729L (no) | Antagonister av det gonadotropinfrigj°rende hormon | |
NO982730L (no) | Antagonister av det gonadotropinfrigj°rende hormon | |
AR061475A1 (es) | Compuestos peptidicos para tratar status epilepticus refractario | |
IS8058A (is) | Sýklísk súlfónamíð til að hamla gamma seytiasa | |
NO944930D0 (no) | Hemming av dysfunksjonell uterin blödning | |
DK0659411T3 (da) | Fremgangsmåde til forøgelse af libido hos kvinder efter menopausen | |
DE602004031631D1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
Kimoto et al. | Effects of [1-desamino-8-D-arginine] vasopressin and papaverine on rabbit renal pelvis | |
ES2157961T3 (es) | Inhibicion del hirsutismo y la alopecia en mujeres. | |
NZ522948A (en) | Active substance combination containing a compound with an opioid effect and at least one further compound of the thyrotropin releasing hormone analog of formula I in the treatment of pain | |
RU2003133804A (ru) | Способ аутоанальгезии ксенон-кислородной смесью | |
DE60127571D1 (de) | Tiagabine zur behandlung von diabetischer neuropathie | |
CO5251459A1 (es) | Combinacion de trimebutina con un analgesico derivado del opio | |
AR050097A1 (es) | Uso de compuestos peptidicos para tratar dolor en neuropatia diabetica dolorosa | |
RU2000106185A (ru) | Способ определения функционального состояния организма человека | |
AR050196A1 (es) | Uso de compuestos peptidicos para tratar esclerosis lateral amiotrofica |